Extrapulmonary Small Cell Neuroendocrine Carcinoma
1 clinical trials · Condition
◉ Watch Extrapulmonary Small Cell Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs (NCT03896503) | National Cancer Institute (NCI) | 2019-12-30 |
Track Extrapulmonary Small Cell Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.